The maracaibo city metabolic syndrome prevalence study: Design and scope

American Journal of Therapeutics

Volumn 17, Issue 3, 2010, Pages 288-294

  Bermúdez, Valmore ^a   Marcano, Rafael París ^a   Cano, Clímaco ^a   Arráiz, Nailet ^a   Amell, Anilsa ^a   Cabrera, Mayela ^a   Reyna, Nadia ^a   Mengual, Edgardo ^a   Vega, Lijuzu ^a   Finol, Freddy ^a   Luti, Yettana ^a   Sánchez, Deysiree ^a   Sánchez, Wireynis ^a   González, Jesús ^a   Montes, Jennifer ^a   Rojas, Edward ^a   Cano, José ^a   Cano, Raquel ^a   Velasco, Manuel ^b   Miranda, José López ^c  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Blood pressure; Cardiovascular risk factors; Cross sectional studies; Dyslipidemia; Metabolic syndrome

Indexed keywords

ADULT; ALCOHOLISM; ANTHROPOMETRY; ARTICLE; ATHEROGENESIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEEDING BEHAVIOR; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PILOT STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RACE; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SOCIAL STATUS; VENEZUELA;

CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PILOT PROJECTS; PREVALENCE; RESEARCH DESIGN; RISK FACTORS; VENEZUELA;

EID: 77952466898     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181c121bc     Document Type: Article

References (32)

1. Liberopoulos EN, Mikhailidis DP, Elisaf MS. Diagnosis and management of the metabolic syndrome in obesity. Obes Rev. 2005;6:283-296.
2. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, et al. The metabolic syndrome: a concept hard to define. Arch Med Res. 2005;36:223-231.
3. Meigs JB, Wilson PW, Nathan DM, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:2160-2167.
4. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
5. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 Initially Healthy American Women. Circulation. 2003;107:391-397.
6. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414-419.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
8. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. 2005. Brusells, Belgium.
9. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
10. Onat A, Uyarel H, Hergenxç G, et al. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis. 2007;191:182-190. (Pubitemid 46237629)
11. Termizy HM, Mafauzy M. Metabolic syndrome and its characteristics among obese patients attending an obesity clinic. Singapore Med J. 2009;50:390-394.
12. National Institute of Statistics. Health Statistics Report of Zulia State 2003. Table 9 Main causes of death according to gender, rates and percentages. Maracaibo Municipality. Zulia State 2003.
13. Thompson D, Edelsberg J, Kinsey KL, et al. Estimated economic costs of obesity to U. S. business. Am J Health Promot. 1998;13:120-127.
14. Méndez-Castellano H, De Méndez MC. Estratificación social y biología humana: método de Graffar modificado. Arch Ven Pueric Pediatr. 1986;49:93-104.
15. Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381-1395.
16. Bernal LP, Castro-Guerra D, Villasmil MG, et al. VNTR Locus D1S80: application to the study of a Mixed Venezuelan sample. Am J Hum Biol. 2000;12:616-622.
17. Pearson TA. Alcohol and heart disease. Circulation. 1996;94:3023-3025.
18. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252:1905-1907.
19. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
20. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the study of insulin resistance (EGIR). Diabetes Med. 1999;16:442-443.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
22. Alexander CM, Landsman PB, Teutsch SM, et al. NCEP- defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52:1210-1214.
23. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237-252.
24. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome 2005. Available at: http://www.idf.org/webcast/pdf/. Accessed June 23, 2009.
25. Eduardo A, Alberto C, Martín L, et al. Prevalencia del Síndrome Metabólico en población laboral española: registro MESYAS. Rev Esp Cardiol. 2005;58:797-806.
26. Olaiz G, Rojas R, Barquera S, et al. Encuesta Nacional de Salud. 2000. Tomo 2. La salud de los adultos. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública, 2003.
27. Palomo I, Icaza G, Mujica V, et al. Prevalencia de factores de riesgo cardiovascular clásicos en población adulta de Talca, Chile, 2005. Rev Méd Chile. 2007;135:904-912.
28. López Súrez A, Elvira González J, Beltrán Robles M, et al. Prevalencia de obesidad, diabetes, hipertensión, hipercolesterolemia y síndrome metabólico en adultos mayores de 50 años de Sanlúcar de Barrameda. Rev Esp Cardiol. 2008;61:1150-1158.
29. García F, Solís J, Calderón J, et al. Prevalencia de diabetes mellitus y factores de riesgo relacionados en una población urbana. Rev Soc Peru Med Interna. 2007;20:90-94.
30. Figueredo Grijalba R, Martínez S, Barriocanal L, et al. Prevalencia de obesidad y distribución de-grasa corporal en Asunción y Area metropolitana. Abstracts del 4to Congreso Latinoamericano de Obesidad, Buenos Aires, E6 Argentina, 1999.
31. Munguía-Miranda C, Sánchez-Barrera RG, Hernández- Saavedra D, et al. Prevalencia de dislipidemias en una población de sujetos en apariencia sanos y su relación con la resistencia a la insulina. Salud Pública México. 2008;50:375-382.
32. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 1962;14:353-362.